Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06976515 · ClinicalTrials.gov registry record
Study for Remote Investigation of Evaporative Dry Eye Disease
A clinical trial of Evaporative Loss Dry Eye Disease, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 90
- Enrollment target
- 1
- Study location
NCT06976515: Recruiting study of Evaporative Loss Dry Eye Disease, sponsored by University of California, San Francisco.
NCT06976515 is a study of Evaporative Loss Dry Eye Disease that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 90 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06976515, a study of Evaporative Loss Dry Eye Disease, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
Dry eye disease is a common problem that can make your eyes feel uncomfortable and affect your vision, making daily tasks harder. Many past studies on dry eye treatments haven't worked well because they didn't include enough people or different types of people. Doing studies at home instead of at the doctor's office can help more people join and make it easier to find out which treatments really work.
Primary Outcome
The primary outcome is the rate of successful completion of the OSDI and SPEED surveys at two time points and the receipt of two clinical samples from two time points.
Conditions Studied
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2025-09-01 |
| Est. Completion | 2027-07-01 |
What NCT06976515 shows while recruiting
NCT06976515 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 1 condition, with Evaporative Loss Dry Eye Disease appearing as the primary indexed condition, and to 0 interventions.
NCT06976515 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06976515 about?
NCT06976515 is a clinical study titled "Study for Remote Investigation of Evaporative Dry Eye Disease". Dry eye disease is a common problem that can make your eyes feel uncomfortable and affect your vision, making daily tasks harder. Many past studies on dry eye treatments haven't worked well because they didn't include enough people or different types of people. Doing studies at home instead of at th...
What is the current status of trial NCT06976515?
This trial is currently recruiting. The enrollment target is 90 participants. The study started on 2025-09-01. Estimated completion is 2027-07-01.
What conditions does trial NCT06976515 study?
This clinical trial studies the following conditions: Evaporative Loss Dry Eye Disease.
Who is sponsoring clinical trial NCT06976515?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06976515 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI